MétaCan
Menu
Back to cohort
Record W4414040538 · doi:10.1002/cam4.71218

Impact of Population Pharmacogenomics on Cisplatin‐Induced Neurotoxicities in Testicular Cancer Survivors

2025· article· en· W4414040538 on OpenAlexaff
Swetha Nakshatri, Paul C. Dinh, Lawrence H. Einhorn, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, C. Kollmannsberger, Robert Huddart, Lois B. Travis, Nancy J. Cox, M. Eileen Dolan

Bibliographic record

VenueCancer Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicCancer Treatment and Pharmacology
Canadian institutionsUniversity of British ColumbiaPrincess Margaret Cancer Centre
FundersNational Institute of General Medical SciencesNational Institutes of HealthNational Cancer InstituteRegeneron Pharmaceuticals
KeywordsPharmacogenomicsPopulationTesticular cancerPeripheral neuropathyAlleleAllele frequencyIncidence (geometry)Cancer

Abstract

fetched live from OpenAlex

ABSTRACT Background Cisplatin is a commonly used chemotherapeutic across numerous cancer types that can cause neurotoxicities in patients, including peripheral sensory neuropathy, tinnitus, hearing loss, and vertigo. Objective We aimed to evaluate, for the first time, how genetic ancestry impacts cisplatin‐induced neurotoxicities and if disparities are related to population differences in allele frequency. Methods In a cohort of cisplatin‐treated testicular cancer survivors, relationships between genetic ancestry and neurotoxicities, medications, and lifestyle factors were assessed using logistic regression and Kruskal–Wallis tests and multiple pairwise comparisons using the Wilcoxon rank‐sum test (Benjamini–Hochberg adjustment). Associations between single nucleotide polymorphism (SNP) genotypes and neurotoxicities with significant inter‐population disparities were calculated to identify independent, functional variants with population allele frequency differentiation associated with toxicities. Results Following four cycles of cisplatin‐based chemotherapy, African ancestry survivors were significantly more likely to have neuropathy and vertigo versus European and Asian‐axis ancestry survivors, although Asian axis survivors were significantly younger at evaluation than other ancestries. Following filtering for population allele frequency differentiation, functional relevance, and independence, 19,992 SNPs were tested for association with toxicities. Although none passed the Bonferroni threshold, two and four SNPs were associated with neuropathy and vertigo, respectively, at suggestively significant p < 1.0 × 10 −4 . For neuropathy, rs34904346 ( p = 2.0 × 10 −5 ) was an expression quantitative trait locus (eQTL) for RNF24 in nerve tissue, with three other RNF24 eQTLs associated with neuropathy ( p < 0.01). For vertigo, rs3777909 ( p = 3.1 × 10 −5 ) was an eQTL for MFSD4B in nerve and REV3L in brain tissue, along with three other eQTLs for MFSD4B and four for REV3L associated with vertigo ( p < 0.05). In silico, higher MFSD4B and REV3L expression in cancer cell lines were associated with significantly greater cisplatin sensitivity. Conclusion African ancestry was associated with increased cisplatin‐induced peripheral sensory neuropathy and vertigo versus European ancestry. Population allele frequency differences and expression levels of RNF24, MFSD4B, and REV3L were potentially implicated.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.179
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.450
Teacher spread0.403 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer MedicineSame topicCancer Treatment and PharmacologyFrench-language works237,207